Santiago Luiz Alfredo, Silva Jussara Matyelle Rodrigues da, Azevedo Orleâncio Gomes Ripardo de, Vasconcelos Paulo Roberto Leitão de
Master in Surgery, and Physician, Hospital de Olhos Leiria de Andrade, Fortaleza-CE, Brazil. Acquisition of data, technical procedures, manuscript writing.
Fellow Master degree, Pharmacology Department, Universidade Federal do Ceará (UFC), Fortaleza-CE, Brazil. Statistical analysis, analysis and interpretation of data, technical procedures.
Acta Cir Bras. 2020 Feb 7;34(12):e201901206. doi: 10.1590/s0102-865020190120000006. eCollection 2020.
To evaluate the effects of prednisolone against sodium diclofenac both with ciprofloxacin compared to artificial tears on the symptoms and signs of acute viral conjunctivitis.
Study included 37 patients diagnosed with acute conjunctivitis and distributed by three groups: A (1% prednisolone acetate + ciprofloxacin (0.3%); B (Sodium diclofenac (0.1%) + ciprofloxacin (0.3%) and C (artificial tears + ciprofloxacin (0.3%). Patients received medication 6/6 hours daily. Signs and symptoms (e.g. lacrimation, burning, photophobia, etc.) were scored at baseline and on the first, third, fifth and seventh days and in the end of treatment using a standardized questionnaire and slit lamp anterior segment examination.
All three groups demonstrated an improvement in the signs and symptoms of conjunctivitis in their follow-up visits. There was no significant difference in symptom and sign scores between Group A and B and B and C in the study visits ( p >0.05). However, the comparison between groups A and C showed a clinical trend (p=0.05) on third evaluation suggesting better clinical action using the corticosteroids.
The prednisolone acetate was not superior to the use of sodium diclofenac or artificial tears in relieving the signs and symptoms of viral conjunctivitis.
评估泼尼松龙与双氯芬酸钠联用环丙沙星,相较于人工泪液,对急性病毒性结膜炎症状和体征的影响。
研究纳入37例诊断为急性结膜炎的患者,分为三组:A组(1%醋酸泼尼松龙+0.3%环丙沙星);B组(0.1%双氯芬酸钠+0.3%环丙沙星);C组(人工泪液+0.3%环丙沙星)。患者每天6次用药。在基线、治疗第1天、第3天、第5天、第7天以及治疗结束时,使用标准化问卷和裂隙灯眼前节检查对症状和体征(如流泪、烧灼感、畏光等)进行评分。
所有三组在随访中结膜炎的症状和体征均有改善。在研究访视中,A组与B组以及B组与C组之间的症状和体征评分无显著差异(p>0.05)。然而,A组与C组之间的比较在第三次评估时显示出一种临床趋势(p=0.05),表明使用皮质类固醇具有更好的临床效果。
醋酸泼尼松龙在缓解病毒性结膜炎的体征和症状方面并不优于双氯芬酸钠或人工泪液。